Pesquisar
Pharming Group NV
PHARAdicionar à lista de desejos
12.920USD
+0.350+2.78%
Fechamento 05/15, 16:00（ET）Cotações atrasadas em 15 min
910.50MValor de mercado
--P/L TTM
Mais detalhes de Pharming Group NV Empresa
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Informações de Pharming Group NV
Código da empresaPHAR
Nome da EmpresaPharming Group NV
Data de listagemJul 02, 1998
CEOChouraqui (Fabrice)
Número de funcionários- -
Tipo de títulosDepository Receipt
Fim do ano fiscal- -
EndereçoDarwinweg 24
CidadeLEIDEN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísNetherlands
Código postal2333 CR
Telefone31715247400
Sitehttps://www.pharming.com/
Código da empresaPHAR
Data de listagemJul 02, 1998
CEOChouraqui (Fabrice)
Executivos da empresa Pharming Group NV
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen (Steve) Toor
Mr. Stephen (Steve) Toor
Chief Commercial Officer
Chief Commercial Officer
--
--
Mrs. Mireille Sanders
Mrs. Mireille Sanders
Chief Operations Officer
Chief Operations Officer
--
--
Ms. Barbara Yanni
Ms. Barbara Yanni
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Mark J. Pykett, M.D., Ph.D.
Dr. Mark J. Pykett, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Anurag Relan, M.D.
Dr. Anurag Relan, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Leonard Kruimer, CPA
Mr. Leonard Kruimer, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Jabine Van Der Meijs
Ms. Jabine Van Der Meijs
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Steven Baert
Mr. Steven Baert
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ruud Van Outersterp
Mr. Ruud Van Outersterp
Chief Ethics and Compliance Officer
Chief Ethics and Compliance Officer
--
--
Dr. Richard Peters, M.D., Ph.D.
Dr. Richard Peters, M.D., Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen (Steve) Toor
Mr. Stephen (Steve) Toor
Chief Commercial Officer
Chief Commercial Officer
--
--
Mrs. Mireille Sanders
Mrs. Mireille Sanders
Chief Operations Officer
Chief Operations Officer
--
--
Ms. Barbara Yanni
Ms. Barbara Yanni
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Mark J. Pykett, M.D., Ph.D.
Dr. Mark J. Pykett, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Anurag Relan, M.D.
Dr. Anurag Relan, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Leonard Kruimer, CPA
Mr. Leonard Kruimer, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Detalhamento da receita
Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: qua, 13 de mai
Atualizado em: qua, 13 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Silverberg Bernstein Capital Management, LLC
0.06%
NewEdge Advisors, LLC
0.04%
Millennium Management LLC
0.03%
Citadel Advisors LLC
0.03%
SmartHarvest Portfolios, LLC
0.02%
Outro
99.83%
Investidores
Investidores
Proporção
Silverberg Bernstein Capital Management, LLC
0.06%
NewEdge Advisors, LLC
0.04%
Millennium Management LLC
0.03%
Citadel Advisors LLC
0.03%
SmartHarvest Portfolios, LLC
0.02%
Outro
99.83%
Tipos de investidores
Investidores
Proporção
Investment Advisor
0.13%
Hedge Fund
0.05%
Outro
99.82%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
22
135.73K
0.19%
+61.81K
2025Q4
16
59.43K
0.09%
-2.30K
2025Q3
13
60.14K
0.09%
-9.65K
2025Q2
10
57.25K
0.08%
-7.99K
2025Q1
11
75.56K
0.11%
-12.14K
2024Q4
11
75.65K
0.11%
-65.36K
2024Q3
11
69.30K
0.10%
-54.56K
2024Q2
9
52.15K
0.08%
-64.69K
2024Q1
9
45.12K
0.07%
-72.64K
2023Q4
9
45.06K
0.07%
-55.56K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Silverberg Bernstein Capital Management, LLC
50.55K
0.07%
-1.60K
-3.07%
Dec 31, 2025
NewEdge Advisors, LLC
28.87K
0.04%
+28.61K
+11310.28%
Dec 31, 2025
Millennium Management LLC
20.39K
0.03%
+20.39K
--
Dec 31, 2025
Citadel Advisors LLC
17.69K
0.03%
+17.69K
--
Dec 31, 2025
SmartHarvest Portfolios, LLC
12.69K
0.02%
+12.69K
--
Dec 31, 2025
Morgan Stanley & Co. LLC
5.20K
0.01%
+3.38K
+186.50%
Dec 31, 2025
Morgan Stanley Smith Barney LLC
2.50K
0%
--
--
Dec 31, 2025
Geode Capital Management, L.L.C.
2.09K
0%
--
--
Jan 31, 2026
EverSource Wealth Advisors, LLC
904.00
0%
-473.00
-34.35%
Dec 31, 2025
The Nalls Sherbakoff Group, LLC
870.00
0%
--
--
Dec 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
